Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.98 USD
Change Today +0.43 / 0.89%
Volume 2.5M
ZTS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

zoetis inc (ZTS) Snapshot

Open
$48.82
Previous Close
$48.55
Day High
$49.45
Day Low
$48.74
52 Week High
06/25/15 - $55.38
52 Week Low
08/7/14 - $31.67
Market Cap
24.5B
Average Volume 10 Days
3.0M
EPS TTM
$1.45
Shares Outstanding
500.0M
EX-Date
08/11/15
P/E TM
33.8x
Dividend
$0.33
Dividend Yield
0.63%
Current Stock Chart for ZOETIS INC (ZTS)

zoetis inc (ZTS) Details

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The company operates through four segments: the United States; Europe/Africa/Middle East; Canada/Latin America; and Asia/Pacific. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia and treating pain and serious illnesses, such as diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories, such as nutritionals and agribusiness, as well as products and services in complementary areas, including diagnostics, genetics, biodevices, and services. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

10,000 Employees
Last Reported Date: 02/27/15
Founded in 1952

zoetis inc (ZTS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.1M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.6K
Executive Vice President and President of U.S...
Total Annual Compensation: $620.4K
Executive Vice President and President of Int...
Total Annual Compensation: $451.4K
President of Research & Development and Execu...
Total Annual Compensation: $451.4K
Compensation as of Fiscal Year 2014.

zoetis inc (ZTS) Key Developments

Zoetis Inc. Declares Third Quarter 2015 Dividend, Payable on Sept. 1, 2015

The Board of Directors of Zoetis Inc. has declared a third quarter 2015 dividend payable to holders of the company's common stock of $0.083 per share. The dividend is to be paid on Sept. 1, 2015, to holders of record on Aug. 13, 2015.

Zoetis Seeks Acquisitions

Zoetis Inc. (NYSE:ZTS) is looking for acquisitions. Zoetis Inc. filed a shelf registration to sell securities. Zoetis intends to use net proceeds from the sale of the securities for general corporate purposes, including working capital, capital expenditures, acquisitions and the refinancing of existing debt.

Valeant Reportedly Made A Preliminary Approach To Buy Zoetis

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has made a preliminary approach to buy Zoetis Inc. (NYSE:ZTS), people familiar with the matter said. The shares of Zoetis rose 11% after the rumour to close at $55.38.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTS:US $48.98 USD +0.43

ZTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abaxis Inc $50.06 USD +0.86
IDEXX Laboratories Inc $72.73 USD +1.39
Phibro Animal Health Corp $39.28 USD +0.47
Vetoquinol SA €38.15 EUR +0.14
Virbac SA €216.00 EUR +1.40
View Industry Companies
 

Industry Analysis

ZTS

Industry Average

Valuation ZTS Industry Range
Price/Earnings 41.5x
Price/Sales 5.1x
Price/Book 19.2x
Price/Cash Flow 37.5x
TEV/Sales 4.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit www.zoetis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.